Abstract
•Chemotherapy initiation and subsequent tumor lysis can release immunogenic antigens.•Advanced staged ovarian cancer associated with dermatomyositis.•PARP Inhibitor initiation can worsen paraneoplastic syndromes like dermatomyositis.•Signs and symptoms of dermatomyositis can be confused with chemotherapy side-effects.